Potentiation by Adrenocorticotrophin of the Diabetogenic Action of Growth-Hormone Preparations

Abstract

THE adrenocorticotrophic hormone is not a potent diabetogenic agent in the intact cat1, in contrast to growth hormone. Its influence on the diabetogenic activity of growth-hormone preparations in the intact cat has now been studied, as briefly reported elsewhere2.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Reid, E., J. Endocrinol., 7, xxxvi (1951).

  2. 2

    Reid, E., Diabetic J. (in the press; abstract of communication to Diabetic Association, July 6, 1951).

  3. 3

    Wilhelmi, A. E., personal communication; cf. Wilhelmi, A. E., Fishman, J. B., and Russell, J. A., J. Biol. Chem., 176, 735 (1948).

  4. 4

    Cotes, P. M., Reid, E., and Young, F. G., J. Endocrinol., 6, xiv (1949).

  5. 5

    Reid, E., J. Endocrinol., 7, 120 (1951).

  6. 6

    Engel, F. L., Coggins, W. J., Lynn, W., and Viau, A., Fed. Proc., 10, 39 (1951).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

REID, E. Potentiation by Adrenocorticotrophin of the Diabetogenic Action of Growth-Hormone Preparations. Nature 168, 878–879 (1951). https://doi.org/10.1038/168878b0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.